Evidence map›Paper›PMID 32600951›Full record

ArticleBiologicals : journal of the International Association of Biological Standardization2020

SARS-CoV-2: Virology, epidemiology, immunology and vaccine development.

Marc Baay, Bruno Lina, Arnaud Fontanet, Arnaud Marchant, Melanie Saville, Philippe Sabot, Philippe Duclos, Joris Vandeputte, Pieter Neels

Abstract read
In one paragraph

Article in Biologicals : journal of the International Association of Biological Standardization, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Observational
  2. Cumulative effects of air pollution and climate drivers on COVID-19 multiwaves in Bucharest, Romania.Process safety and environmental protection : transactions of the Institution of Chemical Engineers, Part B · 2022
    Article
  3. Observational
  4. Article
  5. Article
  6. Review
  7. Review
  8. Exploring the linkage between seasonality of environmental factors and COVID-19 waves in Madrid, Spain.Process safety and environmental protection : transactions of the Institution of Chemical Engineers, Part B · 2021
    Article
  9. Review
  10. Review
  11. Article
  12. Predictors of mortality in patients with COVID-19-a systematic review.European journal of integrative medicine · 2020
    Review
  13. Article
  14. SARS-CoV-2 controlled human infection models: Ethics, challenge agent production and regulatory issues.Biologicals : journal of the International Association of Biological Standardization · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Marc BaayP95 Epidemiology & Pharmacovigilance, Leuven, Belgium. Electronic address: marc.baay@p-95.com.
Bruno LinaUniversity Claude Bernard Lyon, VirPath Research Laboratory, Lyon, France. Electronic address: bruno.lina@univ-lyon1.fr.
Arnaud FontanetDepartment of Global Health, Emerging Diseases Epidemiology Unit, Institut Pasteur, Paris, France. Electronic address: arnaud.fontanet@pasteur.fr.
Arnaud MarchantInstitute for Medical Immunology, Université Libre de Bruxelles, Brussels, Belgium. Electronic address: arnaud.marchant@ulb.be.
Melanie SavilleVaccine R&D, CEPI Vaccines, London, UK. Electronic address: melanie.saville@cepi.net.
Philippe SabotInternational Alliance for Biological Standardization - IABS, Geneva, Switzerland. Electronic address: philippe.sabot@iabs.org.
Philippe DuclosADVAC, University of Geneva, Geneva, Switzerland. Electronic address: Philippe.Duclos@unige.ch.
Joris VandeputteInternational Alliance for Biological Standardization - IABS, Geneva, Switzerland. Electronic address: joris.vandeputte@iabs.org.
Pieter NeelsInternational Alliance for Biological Standardization - IABS, Geneva, Switzerland. Electronic address: Pieter.neels@vaccine-advice.be.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This first International Alliance for Biological Standardization Covid-19 webinar brought together a broad range of international stakeholders, including academia, regulators, funders and industry, with a considerable delegation from low- and middle-income countries, to discuss the virology, epidemiology and immunology of, and the vaccine development for SARS-CoV-2.

Indexed as

BetacoronavirusViral VaccinesAdultAgedAged, 80 and overBasic Reproduction NumberCongresses as TopicCoronavirus InfectionsCOVID-19COVID-19 VaccinesDrug DesignFemaleGlobal HealthHumansInternational CooperationInternetCOVID-19 VaccinesViral VaccinesEpidemiologyImmunologySARS-CoV-2Vaccine developmentVirology

Identifiers

PMID32600951
PMCPMC7309765

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.